Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The combination therapy was effective and well-tolerated, especially in young patients.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Baricitinib may effectively treat oral lichen planus.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Some alternative medicine treatments might work for skin conditions, but their effectiveness and safety differ a lot.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Hydroxychloroquine may help treat alopecia areata in children.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Stephen Rothman made important discoveries in dermatology, including the use of PABA in sunscreens, but never profited from his work.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.